Southern Pain and Regenerative Medicine PC

Southern Pain and Regenerative Medicine PC was paid $1.15M by Medicaid between Nov 2018 and Dec 2024, across 38 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	18	$23.60
2019	2,519	$15K
2020	7,800	$63K
2021	28,917	$235K
2022	37,865	$303K
2023	31,390	$300K
2024incomplete	19,982	$230K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	47%	38,484	22,430	$541K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	31%	34,099	22,829	$358K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.8%	2,233	1,304	$67K
80305		4.9%	22,874	13,778	$56K
64493		2.7%	872	427	$31K
64494		1.3%	867	426	$15K
64483		1.1%	243	141	$13K
96136		<1%	5,285	2,858	$10K
20610		<1%	841	385	$10K
G0444	Annual depression screening, 5 to 15 minutes	<1%	6,606	3,570	$9K
93925		<1%	200	145	$7K
96127		<1%	5,094	3,565	$6K

26 more codes

99152		<1%	567	$4K
99153	Mod sedat endo service >5yrs	<1%	543	$4K
G2011	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes	<1%	2,917	$3K
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	<1%	1,942	$3K
93922		<1%	169	$2K
99215	Doctor's office visit, returning patient (complex)	<1%	74	$2K
99203	Doctor's office visit, new patient (routine)	<1%	67	$1K
81025		<1%	391	$997.69
64484		<1%	20	$860.68
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	173	$323.24
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	976	$243.94
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	732	$193.82
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	476	$162.86
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	226	$150.71
77002		<1%	28	$117.18
76937		<1%	19	$109.01
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	17	$108.15
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	313	$43.30
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	88	$28.46
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	303	$15.65
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	537	$14.61
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	21	$11.08
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	33	$10.41
J0690	Injection, cefazolin sodium, 500 mg	<1%	27	$5.38
C9290	Injection, bupivacaine liposome, 1 mg	<1%	37	$2.50
99072		0%	97	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHODGKISS, THOMAS (OWNER)